Short Interest in Clover Health Investments, Corp. (NASDAQ:CLOV) Declines By 8.2%

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 15,080,000 shares, a decline of 8.2% from the January 15th total of 16,420,000 shares. Based on an average daily volume of 6,160,000 shares, the short-interest ratio is presently 2.4 days.

Analysts Set New Price Targets

Separately, Craig Hallum initiated coverage on Clover Health Investments in a research note on Tuesday, December 17th. They set a "buy" rating and a $6.00 price objective for the company.

Hedge Funds Weigh In On Clover Health Investments

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CLOV. SG Americas Securities LLC acquired a new position in shares of Clover Health Investments in the third quarter worth $252,000. Bleakley Financial Group LLC grew its stake in shares of Clover Health Investments by 98.9% during the third quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company's stock worth $57,000 after purchasing an additional 9,988 shares in the last quarter. Foundations Investment Advisors LLC acquired a new position in shares of Clover Health Investments during the third quarter worth $55,000. Wealth Enhancement Advisory Services LLC grew its stake in shares of Clover Health Investments by 20.4% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 118,156 shares of the company's stock worth $333,000 after purchasing an additional 20,044 shares in the last quarter. Finally, Realta Investment Advisors acquired a new position in shares of Clover Health Investments during the third quarter worth $44,000. Hedge funds and other institutional investors own 19.77% of the company's stock.

Clover Health Investments Price Performance

Shares of CLOV stock traded down $0.09 on Friday, hitting $4.40. The stock had a trading volume of 7,714,481 shares, compared to its average volume of 6,151,479. The company's 50 day moving average price is $3.91 and its 200-day moving average price is $3.48. Clover Health Investments has a 1 year low of $0.61 and a 1 year high of $4.87. The firm has a market capitalization of $2.20 billion, a P/E ratio of -22.00 and a beta of 1.99.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.